StockSelector.com
  Research, Select, & Monitor Sunday, September 23, 2018 8:57:08 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
ACADIA Pharmaceuticals Inc.$20.17$1.065.55%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  ACADIA Pharmaceuticals Inc. vs Biotechnology

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.




An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $124.9 Mil $93,638.6 Mil
  Market Cap: $2,519.4 Mil $517,548.6 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 620.7% 42.3%
  Estimated Revenue: 77.6% 104.1%
  Historic Earnings: N/A (35.9%)
  Estimated Earnings: N/A 7.8%
  Stock Price (1 Year): (46.4%) 38.0%
  Cash per Share: (58.6%) 17.4%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 30.0
  Price-to-Sales: 13.6 N/A
  Price-to-Book: 7.5 4.4
  Dividend Yield: N/A N/A
  Market Cap: $2,519.4 Mil $11,251.1 Mil
  Operations
  Net Margin: (136.0%) (1,230.9%)
  Gross Margin: 92.7% 75.5%
  Return on Equity: (.9) (.3)
  Return on Assets: (.8) (.3)
  Balance Sheet
  Current Ratio: 7.6 5.0
  Quick Ratio: 7.5 4.6
  Cash Ratio: 7.0 3.9
  Debt-to-Equity: .1 1.0
  Interest Coverage: N/A 1.7
 Technicals
  Relative-Strength Index: 84.2 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $205.10 $135,366.0 Mil
  Gilead Sciences, Inc.  (GILD) $75.51 $98,767.1 Mil
  Biogen Inc.  (BIIB) $345.41 $71,603.5 Mil
  Celgene Corp.  (CELG) $87.72 $64,263.7 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $390.28 $44,678.1 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.